Page last updated: 2024-08-21

hydrazine and Graft-Versus-Host Disease

hydrazine has been researched along with Graft-Versus-Host Disease in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Ito, S; Kamihara, S; Kiyohara, K; Kowata, S; Maeta, T; Miyajima, S; Nishiya, M; Okano, Y; Oyake, T; Sasaki, R; Sugawara, N; Takano, M1
He, GS; Huang, LF; Jia, JS; Li, L; Lin, SY; Meng, FK; Yang, Y; Zhang, DH1
Fu, R; Han, B; Jiao, W; Lei, M; Liu, L; Liu, R; Miao, M; Wu, D; Zhang, F; Zhang, L; Zhang, Y; Zhao, X1
Ames, NJ; Barb, JJ; Cashion, AK; Childs, R; Faller, LL; Kim, H; Mudra, SE; Paster, BJ; Ranucci, A; Townsley, DM; Wallen, GR1

Other Studies

4 other study(ies) available for hydrazine and Graft-Versus-Host Disease

ArticleYear
[Treatment of secondary engraftment failure with granulocyte colony-stimulating factor and eltrombopag after allogeneic peripheral blood stem cell transplantation in adult T-cell leukemia/lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2021, Volume: 62, Issue:10

    Topics: Aged; Benzoates; Bone Marrow Transplantation; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Leukemia-Lymphoma, Adult T-Cell; Lymphoma; Peripheral Blood Stem Cell Transplantation; Pyrazoles; Transplantation, Homologous

2021
Frontline Therapy Options for Adults With Newly Diagnosed Severe Aplastic Anemia: Intensive immunosuppressive Therapy Plus Eltrombopag or Matched Sibling Donor Hematopoietic Stem Cell Transplantation?
    Transplantation and cellular therapy, 2022, Volume: 28, Issue:9

    Topics: Anemia, Aplastic; Animals; Benzoates; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Immunosuppression Therapy; Pyrazoles; Siblings; Swine

2022
Matched related transplantation versus immunosuppressive therapy plus eltrombopag for first-line treatment of severe aplastic anemia: a multicenter, prospective study.
    Journal of hematology & oncology, 2022, 08-12, Volume: 15, Issue:1

    Topics: Adult; Anemia, Aplastic; Benzoates; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Immunosuppression Therapy; Immunosuppressive Agents; Prospective Studies; Pyrazoles; Retrospective Studies; Treatment Outcome

2022
The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study.
    Annals of hematology, 2019, Volume: 98, Issue:6

    Topics: Adult; Aged; Anemia, Aplastic; Anti-Bacterial Agents; Antilymphocyte Serum; Benzoates; Biodiversity; Cyclosporine; Dental Health Surveys; DNA, Bacterial; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Immunocompromised Host; Immunosuppressive Agents; Male; Microbiota; Middle Aged; Mouth; Pilot Projects; Pyrazoles; Ribotyping; Sequence Analysis, DNA; Smoking; T-Lymphocytes; Tongue; Young Adult

2019